Targeting PI3K/AKT/mTOR pathway to enhance the anti-leukemia efficacy of venetoclax

Shan Cao(Central South University), Xueying Yan(Heilongjiang University of Chinese Medicine), Chenxing Zeng(Central South University), Gan Zhou(Central South University), Qingqing Xie(University of Jinan), Zubair Hussain(Central South University)
Experimental Cell Research
May 11, 2022
Cited by 18


Related Papers